DF
CRL icon

Donoghue Forlines’s Charles River Laboratories CRL Stock Holding History

Donoghue Forlines’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,315
Closed -$1.97M – 209
2021
Q2 		$1.97M Buy
+5,315
New +$1.77M 0.37% 58

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Donoghue Forlines's CRL Position: Q3 2021 in Review

Donoghue Forlines sold out of Charles River Laboratories (CRL) in Q3 2021, closing a stake of 5,315 shares — an estimated $1.97M sold.

Donoghue Forlines first reported a position in CRL in Q2 2021 and held it in 1 quarter. The position peaked at $1.97M in Q2 2021. 676 funds tracked by Wall St. Rank hold CRL as of Q3 2021.

  • Donoghue Forlines reported no remaining Charles River Laboratories position as of Q3 2021 after selling out during the quarter.
  • Donoghue Forlines sold 5,315 Charles River Laboratories shares in Q3 2021, an estimated $1.97M.
  • Donoghue Forlines first reported a position in Charles River Laboratories in Q2 2021 and held it in 1 quarter.
  • Donoghue Forlines's Charles River Laboratories position peaked at $1.97M in Q2 2021.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2021.

Based on Donoghue Forlines's 13F filing for Q3 2021, filed 15 Nov 2021.